CX3CR1
Basic information
Region (hg38): 3:39263495-39281735
Previous symbols: [ "GPR13", "CMKBRL1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CX3CR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 16 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 9 | 3 |
Variants in CX3CR1
This is a list of pathogenic ClinVar variants found in the CX3CR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-39265456-A-G | Benign (Jul 16, 2018) | |||
3-39265530-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
3-39265531-A-T | not specified | Uncertain significance (Aug 13, 2021) | ||
3-39265558-G-A | not specified | Uncertain significance (Dec 16, 2022) | ||
3-39265660-T-C | not specified | Uncertain significance (Oct 06, 2022) | ||
3-39265671-G-A | - | no classification for the single variant (-) | ||
3-39265678-T-C | not specified | Uncertain significance (Jul 30, 2023) | ||
3-39265685-G-A | Likely benign (Aug 30, 2018) | |||
3-39265725-A-G | not provided (-) | |||
3-39265738-G-A | not specified | Uncertain significance (Mar 14, 2023) | ||
3-39265745-C-T | Benign/Likely benign (Apr 01, 2023) | |||
3-39265765-C-T | - | no classification for the single variant (-) | ||
3-39265776-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
3-39265778-C-G | not specified | Uncertain significance (Nov 07, 2022) | ||
3-39265853-A-G | CX3CR1-related disorder | Likely benign (Jul 31, 2019) | ||
3-39265934-A-G | Likely benign (May 25, 2018) | |||
3-39265939-G-A | CX3CR1-related disorder | Likely benign (Mar 21, 2022) | ||
3-39265945-C-T | not specified | Uncertain significance (Aug 17, 2021) | ||
3-39265963-G-A | not specified | Uncertain significance (Dec 20, 2021) | ||
3-39265981-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
3-39266025-G-A | not specified | Uncertain significance (Aug 14, 2023) | ||
3-39266025-G-C | not specified | Uncertain significance (Oct 25, 2023) | ||
3-39266054-G-A | Benign (Jul 04, 2018) | |||
3-39266134-C-A | not specified | Uncertain significance (Nov 03, 2023) | ||
3-39266154-A-G | not specified | Uncertain significance (Dec 13, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CX3CR1 | protein_coding | protein_coding | ENST00000358309 | 2 | 18242 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0614 | 0.876 | 124787 | 0 | 7 | 124794 | 0.0000280 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.08 | 162 | 206 | 0.788 | 0.0000115 | 2563 |
Missense in Polyphen | 47 | 68.084 | 0.69032 | 917 | ||
Synonymous | -0.944 | 101 | 89.6 | 1.13 | 0.00000579 | 764 |
Loss of Function | 1.56 | 3 | 7.67 | 0.391 | 3.30e-7 | 108 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000557 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000265 | 0.0000265 |
Middle Eastern | 0.0000557 | 0.0000556 |
South Asian | 0.0000654 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for the CX3C chemokine fractalkine (CX3CL1); binds to CX3CL1 and mediates both its adhesive and migratory functions (PubMed:9390561, PubMed:23125415). Acts as coreceptor with CD4 for HIV-1 virus envelope protein (in vitro) (PubMed:9726990). Isoform 2 and isoform 3 seem to be more potent HIV-1 coreceptors than isoform 1 (PubMed:14607932). {ECO:0000269|PubMed:14607932, ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:9390561, ECO:0000269|PubMed:9726990}.;
- Disease
- DISEASE: Macular degeneration, age-related, 12 (ARMD12) [MIM:613784]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:15208270}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Chemokine signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);Peptide GPCRs;Chemokine signaling pathway;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Chemokine receptors bind chemokines;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.366
Intolerance Scores
- loftool
- 0.397
- rvis_EVS
- 0.93
- rvis_percentile_EVS
- 89.79
Haploinsufficiency Scores
- pHI
- 0.337
- hipred
- N
- hipred_score
- 0.170
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.00346
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cx3cr1
- Phenotype
- renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- positive regulation of neuroblast proliferation;response to ischemia;chemotaxis;immune response;cellular defense response;cell adhesion;G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;cell-cell signaling;memory;response to wounding;viral process;negative regulation of angiogenesis;calcium-mediated signaling;negative regulation of cell migration;negative regulation of interleukin-1 beta production;social behavior;autocrine signaling;regulation of tumor necrosis factor biosynthetic process;innate immune response;regulation of nitric oxide biosynthetic process;positive regulation of angiogenesis;regulation of synaptic plasticity;regulation of neurogenesis;positive regulation of neurogenesis;leukocyte tethering or rolling;positive regulation of NF-kappaB transcription factor activity;positive regulation of protein kinase B signaling;cell chemotaxis;chemokine-mediated signaling pathway;cellular response to lipopolysaccharide;cellular response to transforming growth factor beta stimulus;negative regulation of hippocampal neuron apoptotic process;multiple spine synapse organization, single dendrite;negative regulation of long-term synaptic potentiation;positive regulation of I-kappaB phosphorylation;regulation of microglial cell migration;negative regulation of apoptotic signaling pathway
- Cellular component
- nucleus;nucleoplasm;plasma membrane;integral component of plasma membrane;external side of plasma membrane;cell surface;neuronal cell body membrane;neuron projection;perinuclear region of cytoplasm;dendritic tree
- Molecular function
- G protein-coupled receptor activity;chemokine receptor activity;protein binding;G protein-coupled peptide receptor activity;C-C chemokine receptor activity;C-X3-C chemokine receptor activity;chemokine binding;C-C chemokine binding;C-X3-C chemokine binding